glp 1 agonists and sglt2 inhibitors SGLT-2 GLP-1 Agonists: First-Line Therapy for Diabetes With Established Cardiovascular Disease Role of GLP-1 Agonists &
Description
Systematic Reviews and Meta-analyses One collaborative meta-analysis that synthesized the cardiovascular outcomes reported the results from four studies and 45,568 patients on the add-on therapy modalities [20]
Can J Diabetes 2020;44:575-91
Intestinal L cells-derived GLP-1 induce insulin secretion in response to meal intake
For women in perimenopause and menopause, dosing decisions should follow a structured evaluation
